放射性核素<sup>32</sup>P治疗真性红细胞增多症的探讨

李建国; 倪济苍; 陈显煜; 罗加; 李小放

doi:10.13406/j.cnki.cyxb.2000.03.025

您当前的位置：

首页 >

文章列表页 >

放射性核素³²P治疗真性红细胞增多症的探讨

更新时间：2024-01-17

- 放射性核素³²P治疗真性红细胞增多症的探讨
- Probe in treatment of polycythemia vera （PV） by the radioactive nuclide ³²P
- 重庆医科大学学报 2000年第3期页码：290-292
- 作者机构：
  
  重庆医科大学临床学院核医学科,400016
- 作者简介：
- 基金信息：
- DOI：10.13406/j.cnki.cyxb.2000.03.025
  中图分类号： R555.1;R817.5
- 纸质出版日期：2000，
扫描看全文
[1]李建国,倪济苍,陈显煜,罗加,李小放.放射性核素~(32)P治疗真性红细胞增多症的探讨[J].重庆医科大学学报,2000(03):290-292+297.

Probe in treatment of polycythemia vera （PV） by the radioactive nuclide ³²P[J]. Journal of Chongqing Medical University, 2000,(3):290-292.
[1]李建国,倪济苍,陈显煜,罗加,李小放.放射性核素~(32)P治疗真性红细胞增多症的探讨[J].重庆医科大学学报,2000(03):290-292+297. DOI： 10.13406/j.cnki.cyxb.2000.03.025.

Probe in treatment of polycythemia vera （PV） by the radioactive nuclide ³²P[J]. Journal of Chongqing Medical University, 2000,(3):290-292. DOI： 10.13406/j.cnki.cyxb.2000.03.025.

摘要

目的采用放射性核素３２Ｐ治疗真性红细胞增多症（ＰＶ）的疗效、疗程、剂量及生存期等问题的探讨。方法１３例ＰＶ患者进行３２Ｐ口服或静脉注射治疗，治疗后定期随访，确定有复发者给予下一疗程的治疗。随访时间１～１９年。结果１３例ＰＶ病人的症状体征均有不同程度的改变，７例缓解（５３．８％），６例好转（４６％），总有效率（１００％）。生存期延长，平均１３．８年。结论３２Ｐ治疗ＰＶ疗效好，而且简便、安全，治疗剂量易掌握，无明显的毒副反应，导致转化成其它骨髓增生性疾患（ＭＰＤ）的风险与其自然发展过程无明显差别。一旦ＰＶ的诊断成立，建议及时地采用３２Ｐ治疗。

Abstract

Objective Probe of the curative effect

course of treatment

dosage

existing period etc

in the treatment of polycythmia vera (PV) by the

rdioactive32P. Methods 13 cases with PV were treated by32P taken orally or by intravenous injections. Regular follow-up after treatment was conducted. The ascertained patient having a relapse was given the next course of treatment. Time of follow-up was 1-19 years. Results Symptoms and physical signs of all the 13 patients with PV have changed in varying degrees. Among them 7 cases remitted (53.8%)

6 cases got better (46%). General efficiency is 100% .Existing period prolonged and the averages 13.8 years. Conclusion Treating PV by 32P is more effective than other method

it is simple and convenient and easy to master the dosage in treatment. Risk and its naturally developing process leading to other MPD have no evident difference. Once the diagnosis of PV is tenable

it is better to select 32P first for treatment.

关键词

放射性核素32P真性红细胞增多症疗程剂量生存期转化

Keywords

Radioactive nuclide 32Ppolycythemia vera (PV)Course of treatmentDosageExist periodTransform

references

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

高强度聚焦超声损伤兔肝脏的剂量及二维超声实时监控

放射性核素32P治疗真性红细胞增多症的探讨

Probe in treatment of polycythemia vera （PV） by the radioactive nuclide 32P

DOI：10.13406/j.cnki.cyxb.2000.03.025

摘要

Abstract

关键词

Keywords

references

放射性核素³²P治疗真性红细胞增多症的探讨

Probe in treatment of polycythemia vera （PV） by the radioactive nuclide ³²P